Published 3 days ago • loading... • Updated 2 days ago

Philips initiates trial to test X-ray dose technology for CAD

Summary by Medical Device Network

Philips has initiated the RADIQAL trial to assess its new ultra-low X-ray dose technology in treating coronary artery disease (CAD).The post Philips initiates trial to test X-ray dose technology for CAD appeared first on Medical Device Network.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All

Left

Center

Right

redaccionmedica.com

Philips Studies the X-Ray Ulpwork Dose in Coronary Procedures

Royal Philips, world leader in healthcare technology, announced on Thursday the launch of the Radiqal trial (Radiation Dose and Image Quality Trial). This multicenter, randomized study, sponsored by Philips, will include 824 patients with coronary artery disease in 6 hospitals in Spain, the Czech Republic and the United States. The first patient of the study enrolled in the University Hospital of Aarhus, Denmark. “The ability to reduce radiation…

2 days ago

Read Full Article

diarioestrategia.cl

Philips Launches a Study to Show that Its New X-Ray Technology Reduces Radiation Dose

Royal Philips has announced the launch of the RADIQAL study to test its new X-ray Ulwork dose technology can reduce the radiation dose received by a patient with coronary artery disease without affecting the performance of the procedure.

2 days ago

Read Full Article